Nuvalent, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of preferred stock tranche rights
Stock-based compensation expense
Non-cash interest income on promissory note
Net accretion on marketable securities
Change in fair value of related party revenue share liability
Other non-cash

Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities
Proceeds from maturities and sales of marketable securities
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of convertible preferred stock and preferred stock tranche rights, net of issuance costs
Proceeds from initial public offering, net of underwriting discounts and commissions
Proceeds from issuance of common stock, net
Proceeds from exercise of stock options
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from repayment of promissory note to stockholder
Payments of equity issuance costs
Payments of insurance costs financed by a third-party
Net cash provided by financing activities

Net increase in cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of noncash investing and financing information:
Operating lease right-of-use asset
Equity issuance costs
Insurance premium financed by a third-party
Public offering costs included in accounts payable
Settlement of notes payable and accrued interest for preferred stock
Conversion of convertible preferred stock to common stock upon initial public offering
Loss on extinguishment of debt
Settlement of preferred stock tranche rights

Comments